All In Biotech

Drug Trial Radar · NCT01566539

Biological Basis of Individual Variation in Social Cooperation

The Biological Basis of Individual Variation in Social Cooperation

Last checked: Nov 19, 2026Latest source record: Sep 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 707 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

707

Actual

Start

Apr 2008

Primary completion

Nov 2016

Study completion Nov 2016

Sponsor

Lead sponsor
Emory UniversityAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Institute of Mental Health (NIMH); John Templeton Foundation
First posted
Mar 29, 2012

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Factorial
Masking
Triple (participant, care provider, investigator)
Primary purpose
Basic science
Who can join
All sexes, from 18 years, up to 30 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

The project has three overall objectives. The first is to determine whether and how administration of intranasal oxytocin (OT) and intranasal vasopressin (AVP) influence cooperative decision-making and neural responses to cooperative and un-cooperative social interactions. The second is to determine whether and how intranasal vasopressin influences subjective evaluations of and neural responses to same and opposite-sex face stimuli and to determine if any of these effects persist beyond the period of AVP exposure. The third objective is to determine if intranasal OT influences empathy-related behavior and associated brain activity.

Conditions

  • Healthy

Interventions

  • Intranasal Oxytocin (OT) 24 IUDrug

    Participants will self-administer a single dose of 24 international units (IU) oxytocin. Five puffs per nostril, each with 2.4 IU oxytocin. Ten puffs total.

  • Intranasal Vasopressin (AVP)Drug

    Participants will self-administer a 1 ml solution containing 20 units of AVP. Five puffs per nostril, each with 2 International Units (IU) AVP. Ten puffs total).

  • Intranasal PlaceboDrug

    Participants will receive placebo sprays that are pH adjusted to comparable levels of the drugs given. Five puffs per nostril; ten puffs total.

  • Intranasal Vasopressin (AVP) 40 IUDrug

    Participants will self-administer a 0.5 ml solution containing 40 international units (IU) of AVP. 5 puffs in total, each with 4 International Units (IU) AVP.

  • LorazepamDrug

    Subjects will take 1.0 mg of lorazepam orally 60 minutes prior to fMRI scan.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Healthy Volunteers-OT, Placebo: Mean Percent Signal Change in Right Caudate Nucleus in MenTime frame: Visit 1 (40-100 Minutes Post-Intervention)
  2. Healthy Volunteers-OT, Placebo: Mean Percent Signal Change in Right Caudate Nucleus in WomenTime frame: Visit 1 (40-100 Minutes Post-Intervention)
  3. Healthy Volunteers-AVP, Placebo: Mean Percent Signal Change in Left Insula in MenTime frame: Visit 1 (40-100 Minutes Post-Intervention)
  4. Healthy Volunteers-AVP, Placebo: Mean Percent Signal Change in Left Insula in WomenTime frame: Visit 1 (40-100 Minutes Post-Intervention)
  5. Within Subject Group: Mean Percent Signal Change in Left Caudate Nucleus in Men and WomenTime frame: Visit 1 (30-75 Minutes Post-Intervention), Visit 2 (Up to 2 Weeks)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Emory University Hospital

    Atlanta, Georgia

  • Emory University 1462 Clifton Rd

    Atlanta, Georgia

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.